Table III.
Correlation between candidate genotypes and clinical response (CCyR, MMR)
Referent genotype | N | CCyR at 6M Yes | CCyR at 6M No | P-value | CCyR at 12M Yes | CCyR at 12M No | P-value |
---|---|---|---|---|---|---|---|
CYP3A5*3 (rs776746): | |||||||
C – C | 98 | 59 | 39 | 0.06 | 89 | 9 | ± |
T – C | 13 | 4 | 9 | 12 | 1 | ||
T – T | 1 | 0 | 1 | 0.05 | 0 | 1 | 0.90 |
CC vs. TC + TT | |||||||
Referent genotype | N | MMR at 12M Yes | MMR at 12M No | P-value | MMR at 18M Yes | MMR at 18M No | P-value |
CYP3A5*3 (rs776746): | |||||||
C – C | 98 | 54 | 44 | 0.54 | 70 | 28 | 0.31 |
T – C | 13 | 7 | 6 | 9 | 4 | ||
T – T | 1 | 0 | 1 | 0 | 1 | ||
CC vs. TC + TT | 0.94 | 0.87 | |||||
ABCG2 (rs2231142): | |||||||
G – G | 87 | 52 | 35 | 0.06 | 64 | 23 | 0.23 |
T – G | 23 | 9 | 14 | 14 | 9 | ||
T – T | 2 | 0 | 2 | 1 | 1 | ||
GG vs. TG + TT | 0.06 | 0.15 | |||||
TT vs. GT + GG | 0.39 | 1 |
CCyR – complete hematologic response, MMR – major molecular response ± not evaluated (minor frequency nonresponders).